BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8231078)

  • 1. [Diagnosis and therapy of infections in neutropenic patients].
    Hiddemann W
    Krankenpfl J; 1993 Apr; 31(4):146-50. PubMed ID: 8231078
    [No Abstract]   [Full Text] [Related]  

  • 2. Outpatient oral antibiotics for febrile neutropenic cancer patients.
    Ouvrier MJ; Thery JC; Blot E
    J Clin Oncol; 2006 Dec; 24(35):5614; author reply 5614-5. PubMed ID: 17158551
    [No Abstract]   [Full Text] [Related]  

  • 3. Antimicrobial prophylaxis for infection in neutropenic patients.
    Bodey GP
    Curr Clin Top Infect Dis; 1988; 9():1-43. PubMed ID: 3077285
    [No Abstract]   [Full Text] [Related]  

  • 4. [Empirical antimicrobial therapy in a patient with neutropenia].
    Anttila VJ; Ruotsalainen E
    Duodecim; 2002; 118(21):2241-7. PubMed ID: 12486961
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fever in the neutropenic patient].
    Milpied N
    Rev Prat; 2001 Mar; 51(6):633-7. PubMed ID: 11345865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimethoprim/sulfamethoxazole prophylaxis in neutropenic patients. Reduction of infections and effect on bacterial and fungal flora.
    Kauffman CA; Liepman MK; Bergman AG; Mioduszewski J
    Am J Med; 1983 Apr; 74(4):599-607. PubMed ID: 6837588
    [No Abstract]   [Full Text] [Related]  

  • 7. Antifungal prophylaxis and the rate of bacteremia among neutropenic patients.
    Viscoli C; Paesmans M;
    Clin Infect Dis; 2002 Jan; 34(2):289-91. PubMed ID: 11740722
    [No Abstract]   [Full Text] [Related]  

  • 8. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I; Sanz MA
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of infections in patients with acute leukemia.
    Sarkodee-Adoo CB; Merz WG; Karp JE
    Oncology (Williston Park); 2000 May; 14(5):659-66, 671-2; discussion 672-7. PubMed ID: 10853459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of infections in cancer patients with the help of antimicrobial agents].
    Syrjänen J; Kujala P; Sinisalo M; Lumio J
    Duodecim; 2002; 118(21):2233-9. PubMed ID: 12486960
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prevention of bacterial and fungal infections in neutropenic patients with malignant hematologic diseases].
    Candoni A; Russo D; Salmaso F
    Clin Ter; 1997; 148(1-2):23-8. PubMed ID: 9377834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
    Klastersky J
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Infection prophylaxis in neutropenic patients].
    Capdevila JA; Pahissa A
    Enferm Infecc Microbiol Clin; 1997 Dec; 15(10):544-51. PubMed ID: 9522519
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and epidemiological features of infections in the neutropenic patient].
    Viscoli C; Castagnola E
    Haematologica; 1989 Oct; 74(5 Suppl):287-96. PubMed ID: 2512215
    [No Abstract]   [Full Text] [Related]  

  • 15. The importance of prophylactic management of chemotherapy-induced neutropenia.
    Repetto L; Accettura C
    Anticancer Drugs; 2003 Oct; 14(9):725-30. PubMed ID: 14551505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Index to predict invasive mold infection in high-risk neutropenic patients based on the area over the neutrophil curve.
    Portugal RD; Garnica M; Nucci M
    J Clin Oncol; 2009 Aug; 27(23):3849-54. PubMed ID: 19597026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the risk for infection in patients with neutropenia.
    Klastersky JA; Meert AP
    Intensive Care Med; 2016 Feb; 42(2):268-70. PubMed ID: 26170099
    [No Abstract]   [Full Text] [Related]  

  • 18. Neutropenic fever syndromes in patients undergoing cytotoxic therapy for acute leukemia and myelodysplastic syndromes.
    Bow EJ
    Semin Hematol; 2009 Jul; 46(3):259-68. PubMed ID: 19549578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for mannan/mannose-binding lectin (MBL) in defence against infection following chemotherapy for cancer?
    Klein NJ; Kilpatrick DC
    Clin Exp Immunol; 2004 Nov; 138(2):202-4. PubMed ID: 15498027
    [No Abstract]   [Full Text] [Related]  

  • 20. Outpatient oral antibiotics for febrile neutropenic cancer patients using a score predictive for complications.
    Klastersky J; Paesmans M; Georgala A; Muanza F; Plehiers B; Dubreucq L; Lalami Y; Aoun M; Barette M
    J Clin Oncol; 2006 Sep; 24(25):4129-34. PubMed ID: 16943529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.